Quest Diagnostics (DGX) Revenue — Quarter Ended Mar 31, 2023
Revenue for the quarter declined. The decrease was against both the immediately preceding quarter and the same quarter one year earlier.
Key takeaway
Quarter ended Mar 31, 2023 · FY2023 Q1
Revenue for the quarter declined. The decrease was against both the immediately preceding quarter and the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.3B
Revenue reported for this quarter.
Quarter-over-quarter
-0.1%
Change from the immediately preceding quarter.
Year-over-year
-10.7%
Change from the comparable year-ago quarter.
Trailing four quarters
$9.6B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2022 | $2.5B | -3.8% |
| Sep 30, 2022 | $2.5B | -10.4% |
| Dec 31, 2022 | $2.3B | -15.0% |
| Mar 31, 2023 | $2.3B | -10.7% |
Revenue performance
The reported revenue was lower than the prior quarter and also below the level seen in the same period a year ago. The decline reflects a continued downward trajectory.
Quarterly comparison
Compared with the prior quarter, revenue edged lower. Versus the same quarter last year, the decrease was more pronounced. The sequential comparison shows a modest decline, while the year-over-year comparison reveals a sharper contraction.
What to watch
Monitor whether the recent revenue declines continue in subsequent quarters.